Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07674420 · ClinicalTrials.gov registry record · NA
Wearable Insoles for Recurrent Diabetic Ulcer Prevention
A NA study, sponsored by Johns Hopkins University.
- Active
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT07674420: Active NA study, sponsored by Johns Hopkins University.
NCT07674420 is a NA study that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07674420, a NA study, is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The primary objective of the study is to demonstrate the clinical advantages of using the Orpyx SI Sensory Insole (SI) system as an adjunct to standard of care, as compared to standard of care alone, in reducing plantar ulceration in high-risk individuals. The investigators aim to understand participant quality of life, the economic impact and cost-effectiveness of the Orpyx SI insole system, and to evaluate participant engagement and compliance.
Interventions
- DEVICE Orpyx Sensory Insole System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2023-10-17 |
| Est. Completion | 2026-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07674420
The ClinicalTrials.gov registry entry for NCT07674420 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Orpyx Sensory Insole System is the first listed.
NCT07674420 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07674420 about?
NCT07674420 is a clinical study titled "Wearable Insoles for Recurrent Diabetic Ulcer Prevention". The primary objective of the study is to demonstrate the clinical advantages of using the Orpyx SI Sensory Insole (SI) system as an adjunct to standard of care, as compared to standard of care alone, in reducing plantar ulceration in high-risk individuals. The investigators aim to understand partici...
What is the current status of trial NCT07674420?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 17 participants. The study started on 2023-10-17. Estimated completion is 2026-11.
What interventions are being tested in trial NCT07674420?
The interventions under investigation include: Orpyx Sensory Insole System (DEVICE).
Who is sponsoring clinical trial NCT07674420?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.